<div class="old-content"><style></style><div class="old-content"><div class="old-content"><strong>Certara</strong><div class="old-content"><br><br>Certara has released version 2.1 of its SYBYL-X molecularmodeling and simulation suite. SYBYL-X 2.1 features a new job control systemthat provides a consistent interface across the entire tool suite. This changeallows jobs to be submitted remotely from Windows, Linux or Mac to any Linuxsystem where SYBYL-X is installed. Certara's QSAR technology is also moreaccessible now.<br><br><div class="old-content"><strong>Certara</strong><div class="old-content"><br><a href="http://www.certara.com/  " target="_blank">www.certara.com</a><div class="old-content">  </div></div></div></div></div></div></div>

September 2013

Certara has released version 2.1 of its SYBYL-X molecular modeling and simulation suite.

Internal Medicine

Certara enhances SYBYL-X drug design and discovery software 

suite

Article

Articles

front-cover-september-2025

September 2025

Research Areas

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.

artboard-1-copy

revvity-signals-logo-1

Revvity Signals

When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.

Speaking the same molecular language in the age of complex therapeutics

Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.

86529-my-green-lab-tell-us-what-you-know-banner-kr

At My Green Lab® we are igniting a global shift toward environmentally responsible scientific research by helping labs to reduce their environmental impact.

mgl-logo-cropped

My Green Lab

Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.

Bringing sustainability into scientific research

Video

3D illustration of RNA molecules on a gradient blue background.

istock-1441467178-1800x900

Charles River 

elegen logo

Elegen

4bb-logo-rgb-colour-blue-r-3

4basebio

With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.

Exploring the RNA therapeutics universe&nbsp;

Infographics

Certara Certara has released version 2.1 of its SYBYL-X molecularmodeling and simulation suite. SYBYL-X 2.1 features a new job control systemthat provides a consistent interface across the entire tool suite. This changeallows jobs to be submitted remotely from Windows, Linux or Mac to any Linuxsystem where SYBYL-X is installed. Certara's QSAR technology is also moreaccessible now. Certara www.certara.com

Certara enhances SYBYL-X drug design and discovery software suite

Related Topics

Published In

September 2013

Subscribe to our eNewsletters

Sponsored

September 2025